Subsequent research confirmed that BPC-157 promotes osteogenesis and accelerates bone healing, particularly under compromised conditions
Improvements with fasting glucose levels and the overall cholesterol profile
Patients seeking weight management support should consult their GP for referral to NHS tiered weight management services, which provide evidence-based, multidisciplinary care
Notably: BPC-157, KPV, MOTs-C, Emideltide (DSIP), Epitalon, Semax (heptapeptide) and TB-500 are among those expected to be reviewed in July 2026 Other substances, including Cathelicidin LL-37, Dihexa Acetate, PEG-MGF, GHK-Cu and Melanotan II, are under consideration for review by early 2027 Non-injectable GHK-Cu is following a slightly different path, with separate evaluation anticipated before February 2027